Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report

Peer Review reports

Original Submission
16 Nov 2015	Submitted	Original manuscript
26 Jan 2016	Reviewed	Reviewer Report - Shashwat Sharad
28 Jan 2016	Reviewed	Reviewer Report - Arun Chauhan
28 Jan 2016	Reviewed	Reviewer Report - Vishal Chandra
28 Mar 2016	Author responded	Author comments - Sara Henderson
Resubmission - Version 2
28 Mar 2016	Submitted	Manuscript version 2
Publishing
8 May 2016	Editorially accepted
11 May 2016	Article published	10.1186/s12885-016-2342-x

Back to article page